(image: Korea Bizwire)
India, Nov. 5 (Korea Bizwire) — 2 November 2018, Coimbatore, India — Fresenius Medical Care, the world’s largest provider of dialysis products and services, in collaboration with Sri Ramakrishna Hospital, today announced the inauguration of a new dialysis center of excellence. Fresenius Medical Care and the hospital, which is a NABH (National Accreditation Board for Hospitals & Healthcare Providers) – accredited healthcare provider in Tamil Nadu state in the South of India, will provide 12 dialysis stations offering advanced dialysis therapies to help meet the growing demand for treatment in Coimbatore.
India has a high prevalence of chronic kidney disease (CKD), which is estimated to affect 17 per cent of the population.1 The rising incidence of CKD is expected to pose major problems for healthcare providers and the Indian economy in future years.2
“A recent study has shown that the number of people undergoing dialysis in India increases by 100,000 each year2. There is an urgent demand for new dialysis centers that are able to provide excellent care for more patients,” said Mr. Punit Kohli, Managing Director, Fresenius Medical Care India.
“The new center provides patients with the high standards of technology, patient comfort and highly-qualified medical staff. By working closely with Sri Ramakrishna Hospital, we have been able to build a center that is tailored to the specific needs of kidney patients in the region,” he said.
The hospital-based center will offer a range of advanced dialysis options including high-flux hemodialysis and online hemodiafiltration (HDF). Online HDF allows better removal of waste products from the blood, contributing to improved survival for patients compared with those receiving standard hemodialysis.3,4 As part of the company’s holistic approach to patient care, the center will offer holiday dialysis, allowing patients travelling from other regions or from overseas to access uninterrupted treatment.
A ribbon-cutting ceremony on 2 November was organized to officially open the center, with Mr. Punit Kohli and Mr. D. Lakshminarayanaswamy, Joint Managing Trustee, SNR Sons Charitable Trust, officiating. The opening will bring the total number of Fresenius Medical Care dialysis centers in India to 43.
“The hospital will be able to expand its clinical versatility with this dialysis center of excellence,” said Mr. D. Lakshminarayanaswamy. ”We are proud to be collaborating with Fresenius Medical Care, a company that is committed to increasing access to dialysis care throughout Tamil Nadu, enabling people with chronic kidney disease to lead more active and fulfilling lives.”
References
- Varughese S, Abraham G. Chronic Kidney Disease in India. Clinical Journal of the American Society of Nephrology. 2018;13(5):802-804. Available from https://cjasn.asnjournals.org/content/early/2018/01/29/CJN.09180817#ref-4. Accessed 24 October 2018.
- Singh A, Farag Y, Mittal B, Subramanian K, Reddy S, Acharya V et al. Epidemiology and risk factors of chronic kidney disease in India – results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrology. 2013;14(1). Available from https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-14-114. Accessed 24 October 2018.
- Maduell et al; High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients, J Am Soc Nephrol 24: 487-497, 2013
- Erratum. JASN May 2014, 25 (5) 1130
ABOUT FRESENIUS MEDICAL CARE
Fresenius Medical Care is the world’s largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,872 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 329,085 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit: www.freseniusmedicalcare.com
ABOUT SRI RAMAKRISHNA HOSPITAL
Sri Ramakrishna Hospital is an NABH Accredited 1000-bed hi-tech multi-specialty medical complex with almost four decades of experience in kidney care and it is situated in the heart of Coimbatore City. The hospital provides advanced technology, surgical and medical techniques and is driven by its founding ethos of providing accessible healthcare, ensuring that patients receive the very best of care at nominal cost with an excellent ambience, well trained courteous staff supported by latest in medical innovation let us make your dialysis experience enjoyable.
For more information, visit www.snrsonstrust.org, www.sriramakrishnahospital.com
DISCLAIMER
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
Attachments
Dr. Alexandra Villar, Senior Director Marketing Communications
Fresenius Medical Care Asia-Pacific Limited
+61 2 9466 8020
Alexandra.Villar@fmc-asia.com
Source: Fresenius Medical Care Asia-Pacific Limited via GLOBE NEWSWIRE
